Delivery Order SPE2DB22D1106-SPE2DB25FEAJ4

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,780.98 firm-fixed-price delivery order is for 4,565,001,992 units of the medication sulfamethoxazole-trimethoprim double-strength (SMX-TMP DS) tablets, to be delivered by June 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,145.28, is for the delivery of sulfamethoxazole-TMP DS tablets over a period ending on January 6, 2025. The contract is a firm fixed-price delivery order type and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.52 firm fixed-price contract is for the delivery of 4567223532 ! SULFAMETHOXAZOLE-TMP DS TABLET 100S, with a period of performance through February 11, 2025. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of SULFAMETHOXAZOLE-TMP DS TABLET 100S, a generic pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,348.37 and a performance period through December 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,038.33, is for the delivery of 4565354659 - Sulfamethoxazole-TMP DS Tablet 500s, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2024 and was awarded on August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.56 firm fixed-price contract is for the procurement of sulfamethoxazole-trimethoprim double-strength (SMX-TMP DS) tablets, a type of antibiotic medication. The contract has a period of performance through February 11, 2025 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,616.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the purchase of 4,566,249,298 units of Sulfamethoxazole-TMP SS Tablets, which are used for various medical treatments. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is a firm fixed-price contract and...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support...
The U.S. government agency Defense Logistics Agency (DLA) awarded a $2,933.18 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of 4567087832 SULFAMETHOXAZOLE-TMP DS TABLET 100S and has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for SULFAMETHOXAZOLE-TMP DS TABLET 500S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,880.94 and a period of performance through September 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies through a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEAJ4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999 through November 2026. The delivery order is for sulfamethoxazole-tmp DS tablets, a type of antibiotic medication, with a ceiling value of $1,297.28 and a completion date of February 27, 2025. The contract is a firm-fixed-price arrangement with no set-aside designation, indicating open competition. This order is part of the DLA's broader efforts to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/28/25, 10:58 AM